510(k) K042261
K042261 is an FDA 510(k) premarket notification submitted by Macropore Biosurgery, Inc. for the device "MACROPORE PURICEL LIPOPLASTY SYSTEM". The FDA issued a decision of Substantially Equivalent on September 20, 2004. The device falls under product code QPB (System, Suction, Lipoplasty For Removal), a Class II device regulated under 21 CFR 878.5040. Macropore Biosurgery, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 20, 2004
- Date Received
- August 23, 2004
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Suction, Lipoplasty For Removal
- Device Class
- Class II
- Regulation Number
- 878.5040
- Review Panel
- SU
- Submission Type
A suction lipoplasty system is a device intended for the removal of adipose tissue for purposes of aesthetic body contouring